ADHD

Alcobra Ltd. News Headlines

$6.4
*  
0.13
1.99%
Get ADHD Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading ADHD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Health Care Sector Update for 01/22/2015: SHPG, NNVC, BMRN
1/22/2015 8:36:41 AM - MT Newswires


Can the Uptrend Continue for Alcobra (ADHD)? - Tale of the Tape
1/19/2015 7:31:19 AM - Zacks.com


Alcobra: Options Opportunity In This Rebounding Biotech
1/15/2015 11:03:00 AM - Seeking Alpha


Alcobra (ADHD) in Focus: Stock Surges 24.5% - Tale of the Tape
1/12/2015 9:11:00 AM - Zacks.com


Health Care Sector Update for 01/09/2015: AGEN,EDAP,CNAT
1/9/2015 3:39:58 PM - MT Newswires


Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog
12/11/2014 3:20:00 PM - Zacks.com


Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog
12/10/2014 2:50:00 PM - Zacks.com


Actavis Launches Generic of Shire's ADHD Drug Intuniv - Analyst Blog
12/2/2014 6:45:00 PM - Zacks.com


Alcobra To Present At Stifel Healthcare Conference; Webcast At 9:10 AM ET
11/18/2014 8:10:00 AM - RTT News


Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
11/14/2014 3:40:00 PM - Zacks.com


Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
11/14/2014 3:39:00 PM - Zacks.com


Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
11/14/2014 2:20:00 PM - Zacks.com


Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
11/14/2014 9:46:00 AM - Zacks.com


Cepheid Shines in Global Market, Raises Revenue Outlook - Analyst Blog
11/13/2014 3:00:00 PM - Zacks.com


Mallinckrodt Plc (MNK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
11/13/2014 7:00:00 AM - Zacks.com


ArQule (ARQL) Catches Eye: Stock Jumps 10.4% - Tale of the Tape
11/11/2014 8:30:00 AM - Zacks.com


Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% - Tale of the Tape
11/7/2014 9:18:07 AM - Zacks.com


Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape
10/31/2014 8:25:00 AM - Zacks.com


Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% - Tale of the Tape
10/30/2014 8:11:00 AM - Zacks.com


Zacks Rank #1 Additions for Tuesday - Tale of the Tape
10/28/2014 8:30:00 AM - Zacks.com


NanoViricides (NNVC) Jumps: Stock Adds 9.4% in Session - Tale of the Tape
10/28/2014 8:04:00 AM - Zacks.com


Shire (SHPG) Gains on Q3 Earnings Beat, Ups Guidance - Analyst Blog
10/27/2014 9:03:00 AM - Zacks.com


Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout - Analyst Blog
10/16/2014 11:47:00 AM - Zacks.com


Shire's NDA on ADHD Candidate SHP465 Suffers Setback - Analyst Blog
10/10/2014 12:00:00 PM - Zacks.com


Alcobra Reveals ADHD Top-line Phase III Data, Shares Down - Analyst Blog
10/8/2014 1:28:00 PM - Zacks.com